Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Evaluation of Hair Loss, Hair Growth, and Skin Improvement in Human Volunteers Following a Double-blind, Placebo-controlled, 1:1 Randomized Trial of 'Olistic Next Women'
Authors not listed
Bionos Biotech S.L. · 2025
Abstract
The goal of this randomized, double-blind, placebo-controlled clinical trial is to find out whether daily oral intake of the nutraceutical Olistic Next Women can reduce hair loss, improve hair growth and quality, and improve signs of skin aging in women with early female-pattern hair loss. One hundred healthy women aged 50-65 years with initial FPHL will be randomly assigned 1:1 to receive either Olistic Next Women or a matching placebo for 6 months. Participants will drink one vial per day for 28 days, rest 2 days each month, and repeat this cycle for the duration of the study.
The main questions are whether Olistic Next Women, compared with placebo, (1) increases hair density and thickness, improves hair growth (anagen/telogen and terminal/vellus ratios), and reduces hair shedding; and (2) improves facial skin parameters related to aging, such as wrinkles, hydration, brightness, elasticity, and firmness. At baseline and at approximately 1, 3, and 6 months, participants will attend clinic visits where hair metrics at two scalp sites will be quantified using HairMetrix imaging; hair shedding will be assessed with standardized comb and wash tests; and hair fiber damage (in a subset) will be evaluated by scanning electron microscopy. Facial skin will be evaluated using 3D wrinkle imaging, Glossymeter, Corneometer, and Cutometer measurements. Participants will also complete the Skindex-29 and a self-perception questionnaire at several time points while maintaining their usual diet and cosmetic routines and avoiding other hair-active treatments or supplements.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Anonymous. (2025). Clinical Evaluation of Hair Loss, Hair Growth, and Skin Improvement in Human Volunteers Following a Double-blind, Placebo-controlled, 1:1 Randomized Trial of 'Olistic Next Women'. <em>Bionos Biotech S.L.</em>. https://clinicaltrials.gov/study/NCT07300813
Vancouver
Anonymous. Clinical Evaluation of Hair Loss, Hair Growth, and Skin Improvement in Human Volunteers Following a Double-blind, Placebo-controlled, 1:1 Randomized Trial of 'Olistic Next Women'. Bionos Biotech S.L.. 2025.
BibTeX
@misc{anon2025Clinic,
title = {Clinical Evaluation of Hair Loss, Hair Growth, and Skin Improvement in Human Volunteers Following a Double-blind, Placebo-controlled, 1:1 Randomized Trial of 'Olistic Next Women'},
author = {Anonymous},
journal = {Bionos Biotech S.L.},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bionos Biotech S.L. 2025
Open access · US-GOV
Clinical Evaluation of the Improvement of Skin Beauty Parameters After Oral Intake of a Collagen Peptides Supplement in Human Volunteers
IAS Skin Care 2026
Open access · US-GOV
Skin Hydration and Facial Aging: A Cross-Sectional Correlational Observational Study Using BT-Analyze Bioimpedance Assessment Across Seven Facial Zones in Women Aged 30-60 Years
Massachusetts General Hospital 2025
Open access · US-GOV
Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Unidade Local de Saúde de Coimbra, EPE 2024
Open access · US-GOV
Effects of Resveratrol Supplementation on Oocyte Quality in Advanced Maternal Aged Women Undergoing in Vitro Fertilization.
Ritamaria Di Lorenzo 2022
Open access · US-GOV
Clinical Trial for the Evaluation of Cucurbita Pepo Flowers Extract to Promote Skin Health
University of Alabama at Birmingham 2007
Open access · US-GOV